Alpha-9 Oncology
Healthcare & Life Sciences
Recent Finacing
Series C
Recent Raise
$175M
Alpha-9 Oncology Inc. develops targeted radiopharmaceuticals to improve cancer treatment.
Focus Areas
Radiopharmaceuticals
Clinical-stage
Cancer treatment
Targeted therapy
Molecule design
R&D expansion.
Investors
